Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes
about
Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody responseStrain-dependent cytotoxic effects of endotoxin for mouse peritoneal macrophagesDeterminants of antigenic molecules responsible for genetically controlled regulation of immune responses.Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulinsImmune responses in vitro. V. Suppression of M, G, and A plaque-forming cell responses in cultures of primed mouse spleen cells by class-specific antibody to mouse immunoglobulins.Functional maturation of thymic lymphocyte populations in vitroBiological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytesGenetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro.Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens.Cellular requirements for the primary in vitro antibody response to DNP-ficoll.Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) miceActivation of a suppressor T-cell pathway by interferon.Oligomeric IgA: the major component of the in vitro primary response of mouse spleen fragments.Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factorRestriction of primary responses to the IgG class and dependency of IgM responses on secondary immunization for the copolymers of L-glutamic acid, L-tyrosine, and L-alanineIn vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants.Immunosuppressive factors from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10. IV. Lack of strain restrictions among allogeneic, nonresponder donors and recipients.Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III.Suppressor T-cell activity in responder X nonresponder (C57BL/10 X DBA/1)F1 spleen cells responsive to L-glutamic acid60-L-alanine30-L-tyrosine10.Antigen-specific suppressor T-cell activity in genetically restricted immune spleen cellsAbility of antigen-specific helper cells to effect a class-restricted increase in total Ig-secreting cells in spleens after immunization with the antigenFeedback suppression of the immune response in vitro. I. Activity of antigen-stimulated B cells.Antigen structural requirements for immunoglobulin isotype switching in mice.Haplotype-specific suppression of antibody responses in vitro. II. Suppressor factor produced by T cells and T cell hybridomas from mice treated as neonates with semiallogeneic spleen cellsHaplotype-specific suppression of antibody responses in vitro. I. Generation of genetically restricted suppressor T cells by neonatal treatment with semiallogeneic spleen cellsRequirement for three signals in "T-independent" (lipopolysaccharide-induced) as well as in T-dependent B cell responses.Requirement for three signals in B cell responses. II. Analysis of antigen- and Ia-restricted T helper cell-B cell interaction.Antigen-specific suppression in genetic responder mice to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). Characterization of conventional and hybridoma-derived factors produced by suppressor T cells from mice injected as neonates with syngeneic GPurification and characterization of an L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)-specific suppressor factor from genetic responder mice.Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice.Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.Identification of Igh-C-linked determinants on suppressor T cell hybrids and factors specific for L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)Rosette-forming ability of thymus-derived lymphocytes in humoral and cell-mediated immunity. II. Helper cell activityX-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defectGenetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses.
P2860
Q34215260-88873A9C-3A69-41C1-AE65-64364302F208Q34451189-E28F8030-3354-467F-BDF2-68AE4AB6279FQ35018149-2DE29E84-2CF5-4814-BE2F-E9896CF6E9E3Q35052433-053F7D0D-79B5-4380-B895-F722894AD6B2Q35208286-B2921B31-BCE5-417A-8B4F-4C0726CE3BE8Q36271483-2F34B265-BE12-4DC9-ABAA-771114A2948DQ36271486-AA979766-5316-41F1-A529-EB78BB2D56E4Q36272188-02AA7B7C-5C59-46C9-ADD7-DCC477C63149Q36272397-A2124FC3-0C33-483F-9CAB-707FC70E4FEEQ36272644-8B378871-625D-40DF-8B35-3963C182BDC4Q36272748-0FDDA476-9326-4BE3-8EBF-667E9EAEBD31Q36273247-4C6C90D6-7417-4051-9B40-2C9B25D611E1Q36273299-A84A6B5A-BE5A-4174-A210-8DBFBC124595Q36273460-A1D06841-2817-4E88-A58F-CDC843921AE7Q36273605-0848CB35-FA97-42DD-AC33-648358ED20CDQ36300231-6802A30C-ABEF-42BE-B8AE-9E7B78F479AAQ36335045-EA946A87-0FF2-471F-A03D-257455C07BEFQ36335251-00E6726E-22C2-4833-87A4-437F0D741910Q36335345-7D00CA68-8F00-43E0-BD96-78A5C76BD9CDQ36339965-B89140DA-A905-4B30-B736-F418D92C8A47Q36340121-B2D0D8DD-4141-4C3D-BB66-31242D2B917CQ36341436-84F930EF-8ADC-4776-B42A-E900CA2766FAQ36342010-045CD8B3-4C1B-43A1-9E0A-8E6EB92D74A3Q36342108-437B9B71-B52D-4436-96A8-9B0BE816CE40Q36342839-347DC091-3973-419F-B632-A1DFC23053D0Q36343440-05F2FE4A-2767-42BA-A798-63D9B9885E4DQ36344303-B2239565-656C-48E9-8314-976D9CEFA35FQ36345308-F84F5876-A08D-4864-A218-0A63B950BCBCQ36345379-31BAC813-A22A-4992-BA20-8E916949BFDEQ36346288-20E8CC13-C6D7-4E31-AB81-4E50EFCD0087Q36346735-526E0BA9-A581-433C-BB29-899B83F2026EQ36347244-BA3C053C-3A5A-48B8-B4E8-DC23C76C1EADQ36349027-4A7A5BF4-8EEE-4C38-8BCC-7DD50BE4EF2EQ36349502-BFD0476E-B3A9-4044-8C62-88D5179D20D3Q36349546-F545FF45-F854-43A1-B1DE-816B8964CBFFQ36350757-B20DD0F0-1B1F-4292-9DE6-232E003EC557Q36357756-C8687586-E097-40F5-9DAA-45417349373DQ36358381-1295A57A-F9F7-4970-AD71-D16DCFE54ECDQ36358846-1410FFA7-6474-4A0C-BD2D-26B4C3DE38BCQ36359380-FC347CBF-3B69-4146-8A5A-6489C714ECB1
P2860
Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@ast
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@en
type
label
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@ast
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@en
prefLabel
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@ast
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@en
P2093
P2860
P356
P1476
Immune responses in vitro. 3. ...... with heterologous erythrocytes
@en
P2093
P2860
P304
P356
10.1084/JEM.134.2.395
P407
P577
1971-08-01T00:00:00Z